In the AJVR article “Equine autologous blood-based products contain variable quantities of transforming growth factor-β1, interleukin-1 receptor agonist, and α2-macroglobulin” (Am J Vet Res. Published online January 30, 2025. doi:10.2460/ajvr.24.11.0363), the following correction is needed:
Whereas the original title used the term interleukin-1 receptor agonist, the authors would like to amend the term to interleukin-1 receptor antagonist. The corrected title in full reads as follows: “Equine autologous blood-based products contain variable quantities of transforming growth factor-β1, interleukin-1 receptor antagonist, and α2-macroglobulin.”
